Financials
- Market Capitalization 2.46 B
- Employee 34
- Founded 2011
- CEO N/A
- Website www.trevitherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG003QGQRB9
- Industry Biotechnologie
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Related tickers
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 1839 | RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 26.19 USD | -0.27% | -0.91% | +1.63% | -13.48% | 2.58 B USD | ||
| 1841 | PGEN Precigen, Inc. - Common Stock | 7.10 USD | -1.25% | -0.42% | +27.70% | +57.08% | 2.54 B USD | ||
| 1849 | NKTR Nektar Therapeutics - Common Stock | 72.88 USD | -2.24% | -2.59% | +2.37% | -0.53% | 2.49 B USD | ||
| 1854 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 9.73 USD | -1.42% | +0.52% | +0.72% | +15.01% | 2.49 B USD |